Dr Reddys Laboratories (RDY) Other Working Capital Changes (2013 - 2019)
Dr Reddys Laboratories (RDY) posted Other Working Capital Changes of -$3.3 million for Q2 2026, down 20.66% on a QoQ basis from -$2.7 million in Q3 2025, and up 13.21% year-over-year from -$2.9 million in Q2 2025.
Analysis
Dr Reddys Laboratories (RDY) Other Working Capital Changes (2013 - 2019) Analysis & Trends
Dr Reddys Laboratories has reported Other Working Capital Changes for 8 years, with the latest figure at -$3.3 million in Q2 2026.
- On a quarterly basis, Other Working Capital Changes rose 13.21% year-over-year to -$3.3 million in Q2 2026; TTM through Jun 2026 was -$15.0 million, a 4.77% increase from a year earlier, with the FY2026 full-year figure at -$13.0 million, up 13.33% from the prior year.
- Other Working Capital Changes was -$3.3 million for Q2 2026 at Dr Reddys Laboratories, down from -$2.7 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $93.6 million in Q1 2018, with the low at -$61.4 million in Q2 2016.
- Average Other Working Capital Changes over 5 years is $10.3 million, with a median of $1.8 million recorded in 2016.
- The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes slumped 102.52% in 2024, then jumped 47.24% in 2025.
- Over 5 years, Other Working Capital Changes stood at -$2.4 million in 2022, then sank by 76.89% to -$4.3 million in 2023, then retreated by 21.13% to -$5.2 million in 2024, then surged by 47.24% to -$2.7 million in 2025, then decreased by 20.66% to -$3.3 million in 2026.
- The last three Other Working Capital Changes figures came in at -$3.3 million (Q2 2026), -$2.7 million (Q3 2025), and -$3.8 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2019 | 61.59 Mn |
| Mar 31, 2019 | 61.59 Mn |
| Dec 31, 2018 | -6.59 Mn |
| Dec 31, 2018 | -6.59 Mn |
| Sep 30, 2018 | 26.28 Mn |
| Sep 30, 2018 | 26.28 Mn |
| Jun 30, 2018 | -31.63 Mn |
| Jun 30, 2018 | -31.63 Mn |
| Mar 31, 2018 | 93.64 Mn |
| Mar 31, 2018 | 93.64 Mn |
| Dec 31, 2017 | -6.32 Mn |
| Dec 31, 2017 | -6.32 Mn |
| Sep 30, 2017 | -11.37 Mn |
| Sep 30, 2017 | -11.37 Mn |
| Jun 30, 2017 | -33.84 Mn |
| Jun 30, 2017 | -33.84 Mn |
| Mar 31, 2017 | 87.23 Mn |
| Mar 31, 2017 | 87.23 Mn |
| Dec 31, 2016 | 13.70 Mn |
| Dec 31, 2016 | 13.70 Mn |